Initially there was no specific way to reverse the anticoagulant effect of dabigatran in you know um so I mean well well um the the the the the the the the event of a major bleeding event, unlike you know I mean well well okay uh you know for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.